Effect of propranolol on the myocardial contractility of normotensive and spontaneously hypertensive rabbits: Relationship of pharmacokinetics and pharmacodynamics
- 1 October 1989
- journal article
- conference paper
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 17 (5) , 551-570
- https://doi.org/10.1007/bf01071349
Abstract
Myocardial contractility of normotensive and spontaneously hypertensive rabbits was determined following an iv bolus injection of propranolol HCl. Left ventricular pressure and dimension were used to calculate the contractility parameters of (dP/dt) max ,maximum fiber shortening velocity V cf , and the slope of the end systolic pressure-end systolic volume line (ESP-ESV line). Hypertension was induced by a methoxamine HCl iv infusion which mimicked the cardiac effects seen in essential hypertension. Propanolol caused a significant decrease in all contractility parameters (pwithin 15min after administration, with a peak effect occurring after 30–35 mins. The pharmacokinetics and pharmacodynamics of propranolol were fit using Hill's equation in conjunction with the concentration of drug in the theoretical effect compartment. The normotensive group of rabbits had a calculated EC (50) of 12.7 ng/ml, while the hypertensive group had an EC 50 of 6.9 ng/ml,indicating that the hypertensive rabbits were much more sensitive to the propranolol than the normotensive group. In addition, the normotensive group of rabbits demonstrated a much different pharmacokinetic-pharmacodynamic relationship than that of the hypertensive group, indicating that the hypertensive state of the animal has a significant effect upon the concentration-effect relationship.Keywords
This publication has 10 references indexed in Scilit:
- Versatile isocratic high-performance liquid chromatographic assay for propranolol and its basic, neutral and acidic metabolites in biological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Receptor binding characteristics and pharmacokinetic properties as a tool for the prediction of clinical effects of beta-blockers.1985
- Mechanism of antihypertensive action of ketanserin in man.BMJ, 1983
- Simultaneous pharmacokinetic and pharmacodynamic modelingJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarineClinical Pharmacology & Therapeutics, 1979
- End-systolic pressure/volume ratio: A new index of ventricular contractilityThe American Journal of Cardiology, 1977
- Systolic pressure--diameter relations in the normal conscious dogCardiovascular Research, 1975
- Abnormalities of Left Ventricular Contraction Induced by Beta Adrenergic BlockadeCirculation, 1971
- A Comparative Study of Nitroglycerin and PropranololCirculation, 1967